Covington & Burling advised ALK-Abelló A/S on the deal. ALK-Abelló A/S (ALK) and ARS Pharmaceuticals, Inc. (ARS Pharma) (Nasdaq: SPRY) announced a strategic license agreement. The...
ALK’s Licensing Agreement with ARS Pharmaceuticals
Selecta Biosciences’ Merger with Cartesian Therapeutics
Covington & Burling advised Selecta Biosciences, Inc. on the transaction, and Foley Hoag advised Cartesian Therapeutics. Selecta Biosciences (Nasdaq:SELB) (“Selecta”) announced its merger with Cartesian Therapeutics and concurrent...